Sailong Pharmaceutical Group Co., Ltd. (002898.SZ)
CNY 10.94
(0.46%)
CNY 10.94
(0.46%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 22.56 Million CNY | 444.21% |
| 2022 | -6.55 Million CNY | -296.44% |
| 2021 | 3.33 Million CNY | 104.64% |
| 2020 | -71.96 Million CNY | -321.48% |
| 2019 | 32.49 Million CNY | -53.71% |
| 2018 | 70.19 Million CNY | -8.61% |
| 2017 | 76.8 Million CNY | 15.78% |
| 2016 | 66.33 Million CNY | -4.31% |
| 2015 | 69.32 Million CNY | 152.5% |
| 2014 | 27.45 Million CNY | -57.53% |
| 2013 | 64.64 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 2.17 Million CNY | -80.5% |
| 2024 Q2 | 1.53 Million CNY | -29.61% |
| 2024 Q3 | -3.32 Million CNY | -316.77% |
| 2023 Q1 | 4 Million CNY | 112.08% |
| 2023 Q3 | 3.82 Million CNY | 6.83% |
| 2023 Q2 | 3.57 Million CNY | -10.66% |
| 2023 Q4 | 11.16 Million CNY | 192.18% |
| 2023 FY | 22.56 Million CNY | 444.21% |
| 2022 FY | -6.55 Million CNY | -296.44% |
| 2022 Q4 | -33.14 Million CNY | -2688.24% |
| 2022 Q3 | 1.28 Million CNY | -78.37% |
| 2022 Q2 | 5.91 Million CNY | 1256.71% |
| 2022 Q1 | -511.69 Thousand CNY | 98.28% |
| 2021 Q3 | 4.11 Million CNY | -51.04% |
| 2021 Q4 | -29.82 Million CNY | -824.83% |
| 2021 Q1 | 3.72 Million CNY | 113.77% |
| 2021 FY | 3.33 Million CNY | 104.64% |
| 2021 Q2 | 8.4 Million CNY | 125.93% |
| 2020 Q4 | -27.01 Million CNY | -178.04% |
| 2020 Q3 | -9.71 Million CNY | -38.06% |
| 2020 Q2 | -7.03 Million CNY | -119.04% |
| 2020 Q1 | -3.21 Million CNY | -129.48% |
| 2020 FY | -71.96 Million CNY | -321.48% |
| 2019 FY | 32.49 Million CNY | -53.71% |
| 2019 Q4 | 10.9 Million CNY | 482.82% |
| 2019 Q3 | -2.84 Million CNY | -113.74% |
| 2019 Q1 | 3.7 Million CNY | -74.27% |
| 2019 Q2 | 20.73 Million CNY | 459.89% |
| 2018 Q1 | 5.11 Million CNY | -79.85% |
| 2018 Q3 | 15.8 Million CNY | -54.67% |
| 2018 Q4 | 14.39 Million CNY | -8.96% |
| 2018 FY | 70.19 Million CNY | -8.61% |
| 2018 Q2 | 34.87 Million CNY | 581.73% |
| 2017 Q4 | 25.38 Million CNY | 35.95% |
| 2017 FY | 76.8 Million CNY | 15.78% |
| 2017 Q1 | 4.88 Million CNY | -73.35% |
| 2017 Q3 | 18.67 Million CNY | -33.0% |
| 2017 Q2 | 27.86 Million CNY | 470.78% |
| 2016 Q4 | 18.32 Million CNY | 38.8% |
| 2016 Q3 | 13.2 Million CNY | 0.0% |
| 2016 FY | 66.33 Million CNY | -4.31% |
| 2015 FY | 69.32 Million CNY | 152.5% |
| 2014 FY | 27.45 Million CNY | -57.53% |
| 2013 FY | 64.64 Million CNY | 0.0% |